Lifelong maintenance of composition, function and cellular/subcellular distribution of proteasomes in human liver

Mechanisms of Ageing and Development

Volumn 141-142, Issue , 2014, Pages 26-34

  Bellavista, Elena ^a   Martucci, Morena ^a   Vasuri, Francesco ^b   Santoro, Aurelia ^a   Mishto, Michele ^a,c   Kloss, Alexander ^c   Capizzi, Elisa ^b   Degiovanni, Alessio ^b   Lanzarini, Catia ^a   Remondini, Daniel ^a   Dazzi, Alessandro ^b   Pellegrini, Sara ^b   Cescon, Matteo ^b   Capri, Miriam ^a   Salvioli, Stefano ^a   D'Errico Grigioni, Antonia ^b   Dahlmann, Burkhardt ^c   Grazi, Gian Luca ^d   Franceschi, Claudio ^a,e,f  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^d REGINA ELENA NATIONAL CANCER INSTITUTE   (Italy)

^e IRCCS ISTITUTO DELLE SCIENZE NEUROLOGICHE DI BOLOGNA   (Italy)

^f CNR   (Italy)

Author keywords

Aging; Gender; Human liver; Immunoproteasome; PA28 regulator; Standard proteasome

Indexed keywords

PROTEASOME;

ADOLESCENT; ADULT; AGING; CYTOLOGY; ENZYMOLOGY; FEMALE; HUMAN; LIVER; MALE; METABOLISM; MIDDLE AGED; PROTEIN DEGRADATION; SEXUAL DEVELOPMENT;

ADOLESCENT; ADULT; AGING; FEMALE; HUMANS; LIVER; MALE; MIDDLE AGED; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTEOLYSIS; SEX CHARACTERISTICS;

EID: 84908701117     PISSN: 00476374     EISSN: 18726216     Source Type: Journal    
DOI: 10.1016/j.mad.2014.09.003     Document Type: Article

References (50)

1. Bellavista E., Mishto M., Santoro A., Bertoni-Freddari C., Sessions R.B., Franceschi C. Immunoproteasome in Macaca fascicularis: no age-dependent modification of abundance and activity in the brain and insight into an in silico structural model. Rejuvenation Res. 2008, 11(1):73-82.
2. Bellavista E., Andreoli F., Parenti M.D., Martucci M., Santoro A., Salvioli S., Capri M., Baruzzi A., Del Rio A., Franceschi C., Mishto M. Immunoproteasome in cancer and neuropathologies: a new therapeutic target?. Curr. Pharm. Des. 2013, 19(4):702-718.
3. Böttcher J.P., Knolle P.A., Stabenow D. Mechanisms balancing tolerance and immunity in the liver. Dig. Dis. 2011, 29(4):384-390.
4. Breusing N., Arndt J., Voss P., Bresgen N., Wiswedel I., Gardemann A., Siems W., Grune T. Inverse correlation of protein oxidation and proteasome activity in liver and lung. Mech. Ageing Dev. 2009, 130(11-12):748-753.
5. Broering R., Lu M., Schlaak J.F. Role of Toll-like receptors in liver health and disease. Clin. Sci. (Lond.) 2001, 121(10):415-426.
6. Cescon M., Grazi G.L., Ercolani G., Nardo B., Ravaioli M., Gardini A., Cavallari A. Long-term survival of recipients of liver grafts from donors older than 80 years: is it achievable?. Liver Transpl. 2003, 9(11):1174-1180.
7. Cescon M., Grazi G.L., Cucchetti A., Ravaioli M., Ercolani G., Vivarelli M., D'Errico A., Del Gaudio M., Pinna A.D. Improving the outcome of liver transplantation with very old donors with updated selection and management criteria. Liver Transpl. 2008, 14(5):672-679.
8. Cevenini E., Monti D., Franceschi C. Inflamm-ageing. Curr. Opin. Clin. Nutr. Metab. Care 2013, 16(1):14-20.
9. Chondrogianni N., Gonos E.S. Proteasome function determines cellular homeostasis and the rate of aging. Adv. Exp. Med. Biol. 2010, 694:38-46.
10. Conboy I.M., Conboy M.J., Wagers A.J., Girma E.R., Weissman I.L., Rando T.A. Rejuvenation of aged progenitor cells by exposure to a young systemic environment. Nature 2005, 433(7027):760-764.
11. Conconi M., Szweda L.I., Levine R.L., Stadtman E.R., Friguet B. Age-related decline of rat liver multicatalytic proteinase activity and protection from oxidative inactivation by heat-shock protein 90. Arch. Biochem. Biophys. 1996, 331(2):232-240.
12. Dahlmann B., Ruppert T., Kuehn L., Merforth S., Kloetzel P.M. Different proteasome subtypes in a single tissue exhibit different enzymatic properties. J. Mol. Biol. 2000, 303(5):643-653.
13. Dasuri K., Zhang L., Ebenezer P., Liu Y., Fernandez-Kim S.O., Keller J.N. Aging and dietary restriction alter proteasome biogenesis and composition in the brain and liver. Mech. Ageing Dev. 2009, 130(11-12):777-783.
14. Ding Q., Martin S., Dimayuga E., Bruce-Keller A.J., Keller J.N. LMP2 knock-out mice have reduced proteasome activities and increased levels of oxidatively damaged proteins. Antioxid. Redox Signal. 2006, 8(1-2):130-135.
15. Ebstein F., Kloetzel P.M., Krüger E., Seifert U. Emerging roles of immunoproteasomes beyond MHC class I antigen processing. Cell. Mol. Life Sci. 2012, 69(15):2543-2558.
16. Ferrington D.A., Gregerson D.S. Immunoproteasomes: structure function, and antigen presentation. Prog. Mol. Biol. Transl. Sci. 2012, 109:75-112.
17. Fiorentino M., Vasuri F., Ravaioli M., Ridolfi L., Grigioni W.F., Pinna A.D., D'Errico-Grigioni A. Predictive value of frozen-section analysis in the histological assessment of steatosis before liver transplantation. Liver Transpl. 2009, 15(12):1821-1825.
18. Franceschi C., Valensin S., Bonafè M., Paolisso G., Yashin A.I., Monti D., De Benedictis G. The network and the remodeling theories of aging: historical background and new perspectives. Exp. Gerontol. 2000, 35(6-7):879-896.
19. Franceschi C., Motta L., Valensin S., Rapisarda R., Franzone A., Berardelli M., Motta M., Monti D., Bonafè M., Ferrucci L., Deiana L., Pes G.M., Carru C., Desole M.S., Barbi C., Sartoni G., Gemelli C., Lescai F., Olivieri F., Marchegiani F., Cardelli M., Cavallone L., Gueresi P., Cossarizza A., Troiano L., Pini G., Sansoni P., Passeri G., Lisa R., Spazzafumo L., Amadio L., Giunta S., Stecconi R., Morresi R., Viticchi C., Mattace R., De Benedictis G., Baggio G. Do men and women follow different trajectories to reach extreme longevity? Italian Multicenter Study on Centenarians (IMUSCE). Aging (Milano) 2000, 12(2):77-84.
20. Gohlke S., Mishto M., Textoris-Taube K., Keller C., Giannini C., Vasuri F., Capizzi E., D'Errico-Grigioni A., Kloetzel P.M., Dahlmann B. Molecular alterations in proteasomes of rat liver during aging result in altered proteolytic activities. Age (Dordr) 2014, 36(1):57-72.
21. Gohlke S., Kloß A., Tsokos M., Textoris-Taube K., Keller C., Kloetzel P.M., Dahlmann B. Adult human liver contains intermediate-type proteasomes with different enzymatic properties. Ann. Hepathol. 2014, 13(4):429-438.
22. Grazi G.L., Cescon M., Ravaioli M., Ercolani G., Pierangeli F., D'Errico A., Ridolfi L., Cavallari A., Mazziotti A. A revised consideration on the use of very aged donors for liver transplantation. Am. J. Transplant. 2001, 1(1):61-68.
23. Grimm S., Ott C., Hörlacher M., Weber D., Höhn A., Grune T. Advanced-glycation-end-product-induced formation of immunoproteasomes: involvement of RAGE and Jak2/STAT1. Biochem. J. 2012, 448(1):127-139.
24. Hansen T.O., Sarup P., Loeschcke V., Rattan S.I. Age-related and sex-specific differences in proteasome activity in individual Drosophila flies from wild type, longevity-selected and stress resistant strains. Biogerontology 2012, 13(4):429-438.
25. Harring T.R., O'Mahony C.A., Goss J.A. Extended donors in liver transplantation. Clin. Liver Dis. 2011, 15(4):879-900.
26. Hayashi T., Goto S. Age-related changes in the 20S and 26S proteasome activities in the liver of male F344 rats. Mech. Ageing Dev. 1998, 102(1):55-66.
27. Hayashi T., Faustman D. NOD mice are defective in proteasome production and activation of NF-kappaB. Mol. Cell. Biol. 1999, 19(12):8646-8659.
28. Hershko A., Ciechanover A. The ubiquitin system. Annu. Rev. Biochem. 1998, 67:425-479.
29. Huber N., Sakai N., Eismann T., Shin T., Kuboki S., Blanchard J., Schuster R., Edwards M.J., Wong H.R., Lentsch A.B. Age-related decrease in proteasome expression contributes to defective nuclear factor-kappaB activation during hepatic ischemia/reperfusion. Hepatology 2009, 49(5):1718-1728.
30. Ishak K., Baptista A., Bianchi L., Callea F., De Grootes F., Gudat F., Denk H., Desmet V., Korb G., MacSween R.N.M., Phillips J., Portmann B.G., Paulsen H., Scheuer P.J., Schmid M., Thaler H. Histological grading and staging of chronic hepatitis. J. Hepatol. 1995, 22:696-699.
31. Keller J.N., Hanni K.B., Markesbery W.R. Possible involvement of proteasome inhibition in aging: implications for oxidative stress. Mech. Ageing Dev. 2000, 113(1):61-70.
32. Mishto M., Bellavista E., Santoro A., Stolzing A., Ligorio C., Nacmias B., Spazzafumo L., Chiappelli M., Licastro F., Sorbi S., Pession A., Ohm T., Grune T., Franceschi C. Immunoproteasome and LMP2 polymorphism in aged and Alzheimer's disease brains. Neurobiol. Aging 2006, 27(1):54-66.
33. Mishto M., Santoro A., Bellavista E., Sessions R., Textoris-Taube K., Dal Piaz F., Carrard G., Forti K., Salvioli S., Friguet B., Kloetzel P.M., Rivett A.J., Franceschi C. A structural model of 20S immunoproteasomes: effect of LMP2 codon 60 polymorphism on expression, activity, intracellular localisation and insight into the regulatory mechanisms. Biol. Chem. 2006, 387(4):417-429.
34. Mishto M., Bellavista E., Ligorio C., Textoris-Taube K., Santoro A., Giordano M., D'Alfonso S., Listì F., Nacmias B., Cellini E., Leone M., Grimaldi L.M., Fenoglio C., Esposito F., Martinelli-Boneschi F., Galimberti D., Scarpini E., Seifert U., Amato M.P., Caruso C., Foschini M.P., Kloetze L P.M., Franceschi C. Immunoproteasome LMP2 60HH variant alters MBP epitope generation and reduces the risk to develop multiple sclerosis in Italian female population. PLoS ONE 2010, 5(2):e9287.
35. Mishto M., Ligorio C., Bellavista E., Martucci M., Santoro A., Giulioni M., Martucci G., Franceschi C. Immunoproteasome expression is induced in mesial temporal lobe epilepsy. Biochem. Biophys. Res. Commun. 2011, 408(1):65-70.
36. Petersen A., Honarvar A., Zetterberg M. Changes in activity and kinetic properties of the proteasome in different rat organs during development and maturation. Curr. Gerontol. Geriatr. Res. 2010, 230697.
37. Pickering A.M., Koop A.L., Teoh C.Y., Ermak G., Grune T., Davies K.J. The immunoproteasome, the 20S proteasome and the PA28αβ proteasome regulator are oxidative-stress-adaptive proteolytic complexes. Biochem. J. 2010, 432(3):585-594.
38. Ravaioli M., Grazi G.L., Cescon M., Cucchetti A., Ercolani G., Fiorentino M., Panzini I., Vivarelli M., Ramacciato G., Del Gaudio M., Vetrone G., Zanello M., Dazzi A., Zanfi C., Di Gioia P., Bertuzzo V., Lauro A., Morelli C., Pinna A.D. Liver transplantations with donors aged 60 years and above: the low liver damage strategy. Transpl. Int. 2009, 22(4):423-433.
39. Rodriguez K.A., Gaczynska M., Osmulski P.A. Molecular mechanisms of proteasomes plasticity in aging. Mech. Ageing Dev. 2010, 131(2):144-155.
40. Rodriguez K.A., Edrey Y.H., Osmulski P., Gaczynska M., Buffenstein R. Altered composition of liver proteasome assemblies contributes to enhanced proteasomes activity in the exceptionally long-lived naked mole-rat. PLoS ONE 2012, 7(5):e35890.
41. Schmeding M., Sauer I., Hartwig K., Theruvath T., Pratschke J., Neuhaus R., Neuhaus P., Neumann U.P. Aging of the liver graft and functional quality in the absence of recurrent disease: a 10 year histological follow-up. Ann. Transplant. 2010, 15(1):5-13.
42. Schmidt F., Dahlmann B., Janek K., Kloß A., Wacker M., Ackermann R., Thiede B., Jungblut P.R. Comprehensive quantitative proteome analysis of 20S proteasome subtypes from rat liver by isotope coded affinity tag and 2-D gel-based approaches. Proteomics 2006, 6:4622-4632.
43. Schmucker D.L., Sanchez H. Liver regeneration and aging: a current perspective. Curr. Gerontol. Geriatr. Res. 2011, 526379.
44. Shibatani T., Nazir M., Ward W.F. Alteration of rat liver 20S proteasome activities by age and food restriction. J. Gerontol. A Biol. Sci. Med. Sci. 1996, 51(5):B316-B322.
45. Shibatani T., Carlson E.J., Larabee F., McCormack A.L., Früh K., Skach W.R. Global organization and function of mammalian cytosolic proteasome pools: implications for PA28 and 19S regulatory complexes. Mol. Biol. Cell. 2006, 17(12):4962-4971.
46. Sixt S.U., Alami R., Hakenbeck J., Adamzik M., Kloss A., Costabel U., Jungblut P.R., Dahlmann B., Peters J. Distinct proteasome subpopulations in the alveolar space of patients with the acute respiratory distress syndrome. Mediat. Inflamm. 2012, 204250.
47. Tajiri K., Shimizu Y. Liver physiology and liver diseases in the elderly. World J. Gastroenterol. 2013, 19(46):8459-8467.
48. Tomaru U., Takahashi S., Ishizu A., Miyatake Y., Gohda A., Suzuki S., Ono A., Ohara J., Baba T., Murata S., Tanaka K., Kasahara M. Decreased proteasomal activity causes age-related phenotypes and promotes the development of metabolic abnormalities. Am. J. Pathol. 2012, 180(3):963-972.
49. Vasuri F., Capizzi E., Bellavista E., Mishto M., Santoro A., Fiorentino M., Capri M., Cescon M., Grazi G.L., Grigioni W.F., D'Errico-Grigioni A., Franceschi C. Studies on immunoproteasome in human liver. Part I: absence in fetuses, presence in normal subjects, and increased levels in chronic active hepatitis and cirrhosis. Biochem. Biophys. Res. Commun. 2010, 397(2):301-306.
50. Vo T.K., Godard P., de Saint-Hubert M., Morrhaye G., Debacq-Chainiaux F., Swine C., Geenen V., Martens H.J., Toussaint O. Differentially abundant transcripts in PBMC of hospitalized geriatric patients with hip fracture compared to healthy aged controls. Exp. Gerontol. 2011, 46(4):257-264.